Take part in research

Take part in research

Research into Parkinson’s continues to be on the rise in Australia and internationally.

Taking part in a research project may result in a better understanding of, or better treatment or a potential cure for Parkinson’s. In some cases, research projects may provide access to new interventions before they are widely available.

Below are current research projects looking for participants

Natural History of Parkinson’s Disease Study
Neuroscience Research Australia (NeuRA)

Overview of study

The 2024_ ETH01333 Natural History of Parkinson’s Disease Study, conducted by Neuroscience Research Australia (NeuRA), seeks to enrol 600 individuals diagnosed with Parkinson’s disease and 100 healthy controls.. This study aims to gain a deeper understanding of Parkinson’s disease progression, enabling more effective treatment strategies and support for those affected.

We are calling on individuals with Parkinson’s disease and healthy individuals to join the Natural History of Parkinson’s Disease Study at Neuroscience Research Australia (NeuRA). This study is an opportunity to contribute to research that could lead to breakthroughs in Parkinson’s treatment and care.

Participant Criteria:
– Parkinson’s Disease: Individuals diagnosed with Parkinson’s disease.
– Healthy Controls: Individuals without Parkinson’s disease.

How to Sign Up:
Fill out the https://forms.gle/fHnj3BnKsKjgM48v5

Contact Information:
For additional questions, please email clinics@neura.edu.au

Thank you for supporting Parkinson’s disease research.

A collaborative project between the research teams at University of Western Australia and The University of Notre Dame Australia are investigating the non-motor symptoms of Parkinson’s.

The research team have been working in the Parkinson’s space for 5 years and invite people living with Parkinson’s to participate in an anonymous online survey (2020/ET000196). This survey will take approximately 30-45 minutes to complete.

For more information view the flyer

The survey can be accessed by clicking this link 

Contact details:
Madison Hoes
madison.hoes@research.uwa.edu.au

Associate Professor Ryan Anderton
ryan.anderton@nd.edu.au

Researchers at University of Queensland’s Centre for Clinical Research are working to improve neuropsychological assessments for earlier and more effective diagnosis of dementia in Parkinson’s disease. In the first stage of the research they are aiming to engage people as many people as possible with Parkinson’s and their family members across Australia to gain their views and experiences of cognitive assessments and diagnosis of Parkinsons disease dementia.

The project will consist of different forms of participation to choose from such as focus groups over zoom, questionnaires completed online or delphi surveys over zoom.

We are looking for people with Parkinson’s disease or their family care partners, who have undergone a neuropsychological or cognitive assessment, regardless of what the outcome was.

To take part you must be:

  • Aged over 18 years
  • Able to communicate in English sufficiently for the provision of consent and participate in the research activities
  • Have a diagnosis of Parkinson’s disease and have undergone a neuropsychological evaluation related to this condition or are a family member or carer of someone with a diagnosis of Parkinson’s disease who has undergone a neuropsychological evaluation.

If you would like to take part in the research or if you would like to discuss the research please find further details here: https://clinical-research.centre.uq.edu.au/pdcognicare

(This study has ethical approval from Metro HREC (HREC/2023/MNHA/100098) and is funded by an NHMRC MRFF grant #2023746)

Research & Clinical Trial Updates

Research into Parkinson’s is happening every day across Australia and around the world. From clinical trials and exercise studies to emerging therapies and technology, these updates help connect the Parkinson’s community with the latest developments, opportunities and conversations in research.

Whether you’re interested in participating in research, learning about new studies or hearing directly from researchers and clinicians, this section will feature updates, webinars and opportunities relevant to the Parkinson’s community.

Latest Webinars & Updates

The Movement Disorder Society of Australia and New Zealand (MDSANZ) Clinical Trials Network hosts webinars featuring researchers, clinicians and experts discussing current Parkinson’s and movement disorder research, emerging treatments and clinical trials.

October 2025 webinar: The Future of movement disorder research

Speakers took viewers behind the scenes of current and upcoming clinical trials, shared new developments in the field, and highlighted research opportunities.

Speakers and topics

  • Alex Lehn: The MDSANZ Clinical Trials Network: updates on current and upcoming clinical trials
  • Niamh Hennessy: TarGAITed Stimulation Trial: stepping towards a non-invasive treatment for Parkinson’s disease walking impairments
  • Lucy Vivash: Clinical trials for Progressive Supranuclear Palsy
  • Aishwarya Mary Johnson: Hitting Parkinson’s where it hurts: a two-pronged attack
  • Richard Gordon: Understanding and targeting the gut microbiome in Parkinson’s disease
Watch the webinar



April 2026 Webinar: Trials, discoveries and the road ahead

Speakers explored the breadth of what the MDSANZ Clinical Trials Network and its partners are working on right now: from the genetics and immune signals that may shape who develops Parkinson’s, to the role of the gut microbiome, cognition, metabolism, and movement itself. We also previewed several new trials opening in our region, including studies in Progressive Supranuclear Palsy.

Speakers and topics

  • Alex Lehn: The MDSANZ Clinical Trials Network: who we are, current and upcoming trials across the region
  • Peter Nestor: Cognitive abilities in Parkinson’s disease
  • Victor Flores Ocampo: Can Parkinson’s be inherited? What genetics can tell us
  • Kunal Bhatt: Listening to the immune system: early clues in Parkinson’s disease
  • Matthew Phillips: Ketogenic metabolic therapy in Parkinson’s and Huntington’s
  • Divya Onkar Mondhe: The microbial mystery of Parkinson’s disease
  • Nadeeka Dissanayaka: Improving identification of cognitive impairment in Parkinson’s disease: the PDCogniCare program
  • Graham Kerr: Connecting brain and muscles for improved balance and gait
Watch the webinar